Discovery of a new nosiheptide-producing strain and its fermentation optimization for nosiheptide production

SUN Qihang; XU Yuncong; WU Lingrui; RONG Jiale; WANG Yanwen; CAO Yudan; LUO Chen; WU Xuri

doi:10.11665/j.issn.1000-5048.20220612

Journal of China Pharmaceutical University > 2022 > 53(6): 725-733. > DOI: 10.11665/j.issn.1000-5048.20220612

SUN Qihang, XU Yuncong, WU Lingrui, RONG Jiale, WANG Yanwen, CAO Yudan, LUO Chen, WU Xuri. Discovery of a new nosiheptide-producing strain and its fermentation optimization for nosiheptide production[J]. Journal of China Pharmaceutical University, 2022, 53(6): 725-733. DOI: 10.11665/j.issn.1000-5048.20220612

Citation:

PDF (1924 KB)

Discovery of a new nosiheptide-producing strain and its fermentation optimization for nosiheptide production

Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing 211198, China

Funds: This study was supported by the National Natural Science Foundation of China (No.81973214)

More Information

Received Date: June 16, 2022
Revised Date: November 22, 2022

Graphical Abstract

Abstract

Abstract

Nosiheptide is a typical thiopeptide antibiotic displaying potent activity toward various drug-resistant strains of Gram-positive pathogens.Although nosiheptide lacks in vivo activity, and good water-solubility with a series of uncontrollable analogues, which may limit its clinical application, glycosylated analogues may overcome problem of low activity and may improve its druggability.In search of novel glycosylated nosiheptide producers, we applied a genome mining strategy that identified Actinoalloteichus sp.AHMU CJ021 that contains all genes required.However, despite the presence of a predicted glycosyltransferase, glycosylated derivatives of nosiheptide were not detected, after following one strain many compounds (OSMAC) strategy and heterologous expression of a regulatory protein NocP.Nevertheless, nosiheptide produced by this strain was remarkably pure, and further experiments were conducted to improve its production by optimization of the culture medium.Under optimal conditions, 58.73 mg/L nosiheptide was produced, representing an almost 6-fold improvement compared to the original fermentation medium.Therefore, we consider Actinoalloteichus sp.AHMU CJ021 a suitable potential candidate for industrial production of nosiheptide, which provides the basis for solving the problem of nosiheptide structural analogues.
- nosiheptide,
- genome mining,
- fermentation,
- biosynthetic gene cluster,
- glycosyltransferase

FullText(HTML)

References (31)

References

[1]	. Nature，2020，582（7811）：294-297.
[2]	Culp EJ，Waglechner N，Wang WL，et al. Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling［J］. Nature，2020，578（7796）：582-587.
[3]	Hutchings MI，Truman AW，Wilkinson B. Antibiotics：past，present and future［J］. Curr Opin Microbiol，2019，51：72-80.
[4]	Furusawa C，Horinouchi T，Maeda T. Toward prediction and control of antibiotic-resistance evolution［J］. Curr Opin Biotechnol，2018，54：45-49.
[5]	Isenman H，Fisher D. Advances in prevention and treatment of vancomycin-resistant Enterococcus infection［J］. Curr Opin Infect Dis，2016，29（6）：577-582.
[6]	Hudson GA，Mitchell DA. RiPP antibiotics：biosynthesis and engineering potential［J］. Curr Opin Microbiol，2018，45：61-69.
[7]	Blair JMA，Webber MA，Baylay AJ，et al. Molecular mechanisms of antibiotic resistance［J］. Nat Rev Microbiol，2015，13（1）：42-51.
[8]	Crofts TS，Gasparrini AJ，Dantas G. Next-generation approaches to understand and combat the antibiotic resistome［J］. Nat Rev Microbiol，2017，15（7）：422-434.
[9]	Harms JM，Wilson DN，Schluenzen F，et al. Translational regulation via L11：molecular switches on the ribosome turned on and off by thiostrepton and micrococcin［J］. Mol Cell，2008，30（1）：26-38.
[10]	Wang B，LaMattina JW，Badding ED，et al. Using peptide mimics to study the biosynthesis of the side-ring system of nosiheptide［J］. Methods Enzymol，2018，606：241-268.
[11]	Yang MY，Zhang JW，Wu XR，et al. Optimization of critical medium components for enhancing antibacterial thiopeptide nocathiacin I production with significantly improved quality［J］. Chin J Nat Med，2017，15（4）：292-300.
[12]	Li WY，Huang S，Liu XH，et al. N-demethylation of nocathiacin I via photo-oxidation［J］. Bioorg Med Chem Lett，2008，18（14）：4051-4053.
[13]	Feng K，Wang SZ，Ma HR，et al. Chirality plays critical roles in enhancing the aqueous solubility of nocathiacin I by block copolymer micelles［J］. J Pharm Pharmacol，2013，65（1）：64-71.
[14]	Xu LB，Farthing AK，Dropinski JF，et al. Synthesis and antibacterial activity of novel water-soluble nocathiacin analogs［J］. Bioorg Med Chem Lett，2013，23（1）：366-369.
[15]	Xu LB，Farthing AK，Dropinski JF，et al. Nocathiacin analogs：synthesis and antibacterial activity of novel water-soluble amides［J］. Bioorg Med Chem Lett，2009，19（13）：3531-3535.
[16]	Ziemert N，Alanjary M，Weber T. The evolution of genome mining in microbes—a review［J］. Nat Prod Rep，2016，33（8）：988-1005.
[17]	Russell AH，Truman AW. Genome mining strategies for ribosomally synthesised and post-translationally modified peptides［J］. Comput Struct Biotechnol J，2020，18：1838-1851.
[18]	Yu Y，Duan L，Zhang Q，et al. Nosiheptide biosynthesis featuring a unique indole side ring formation on the characteristic thiopeptide framework［J］. ACS Chem Biol，2009，4（10）：855-864.
[19]	Liao RJ，Duan L，Lei C，et al. Thiopeptide biosynthesis featuring ribosomally synthesized precursor peptides and conserved posttranslational modifications［J］. Chem Biol，2009，16（2）：141-147.
[20]	Blin K，Shaw S，Steinke K，et al. antiSMASH 5.0：updates to the secondary metabolite genome mining pipeline［J］. Nucleic Acids Res，2019，47（W1）：W81-W87.
[21]	Lin QH，Zhang GT，Li SM，et al. Development of a genetic modification system for caerulomycin producer Actinoalloteichus sp. WH₁-2216-6［J］. Acta Microbiol Sin（微生物学报），2011，51（8）：1032-1041.
[22]	Mocek U，Chen LC，Keller PJ，et al. ¹H and ¹³C NMR assignments of the thiopeptide antibiotic nosiheptide［J］. J Antibiot （Tokyo），1989，42（11）：1643-1648.
[23]	Arias P，Fernández-Moreno MA，Malpartida F. Characterization of the pathway-specific positive transcriptional regulator for actinorhodin biosynthesis in Streptomyces coelicolor A3（2） as a DNA-binding protein［J］. J Bacteriol，1999，181（22）：6958-6968.
[24]	Li JJ，Li Y，Niu GQ，et al. NosP-regulated nosiheptide production responds to both peptidyl and small-molecule ligands derived from the precursor peptide［J］. Cell Chem Biol，2018，25（2）：143-153.e4.
[25]	Ding Y，Yu Y，Pan HX，et al. Moving posttranslational modifications forward to biosynthesize the glycosylated thiopeptide nocathiacin I in Nocardia sp. ATCC202099［J］. Mol Biosyst，2010，6（7）：1180-1185.
[26]	de Vries RH，Viel JH，Oudshoorn R，et al. Selective modification of ribosomally synthesized and post-translationally modified peptides （RiPPs） through Diels-alder cycloadditions on dehydroalanine residues［J］. Chemistry，2019，25（55）：12698-12702.
[27]	Kennedy M，Krouse D. Strategies for improving fermentation medium performance：a review［J］. J Ind Microbiol Biotechnol，1999，23（6）：456-475.
[28]	Schwientek P，Wendler S，Neshat A，et al. Comparative RNA-sequencing of the acarbose producer Actinoplanes sp. SE50/110 cultivated in different growth media［J］. J Biotechnol，2013，167（2）：166-177.
[29]	Maulvi FA，Parmar RJ，Shukla MR，et al. Plackett-Burman design for screening of critical variables and their effects on the optical transparency and swelling of gatifloxacin-Pluronic-loaded contact lens［J］. Int J Pharm，2019，566：513-519.
[30]	Silva CL，Perestrelo R，Silva P，et al. Implementing a central composite design for the optimization of solid phase microextraction to establish the urinary volatomic expression：a first approach for breast cancer［J］. Metabolomics，2019，15（4）：64.
[31]	Pan ZH，Jiao RH，Lu YH，et al. Enhancement of dalesconols A and B production via upregulation of laccase activity by medium optimization and inducer supplementation in submerged fermentation of Daldinia eschscholzii［J］. Bioresour Technol，2015，192：346-353.

[1]	SHI Min, YONG Qin, HE Yingna, HUANG Shiqin, ZHAO Xuan, YU Xian. Construction and in vivo evaluation of a thermosensitive hydrogel system loading with Pseudomonas aeruginosa DNA vaccine[J]. Journal of China Pharmaceutical University, 2021, 52(2): 186-194. DOI: 10.11665/j.issn.1000-5048.20210207
[2]	CHEN Ye, YIN Jun, YAO Wenbing, GAO Xiangdong. Advances of DNA-based nanomaterials in tumor therapy[J]. Journal of China Pharmaceutical University, 2020, 51(4): 406-417. DOI: 10.11665/j.issn.1000-5048.20200404
[3]	WANG Rui, WANG Yongmei, CAI Mingjun, KE Xuejia, WU Yue, CHONG Jun, CAO Rongyue. Pharmacological effects of anti-melanoma DC vaccine sensitized by fusion proteins of G3G6 and HST1[J]. Journal of China Pharmaceutical University, 2019, 50(2): 238-245. DOI: 10.11665/j.issn.1000-5048.20190216
[4]	HAN Xiu, QI Xiaole, WU Zhenghong. Advances in self-assemblied DNA nanocages as drug delivery systems[J]. Journal of China Pharmaceutical University, 2017, 48(6): 663-669. DOI: 10.11665/j.issn.1000-5048.20170605
[5]	ZHANG Zhiqing, WANG Fang, ZHOU Ting, ZHANG Guodong, WANG Xiufeng, LI Yunze. A DNA polyaptamer system as a targeted antitumor drug delivery[J]. Journal of China Pharmaceutical University, 2015, 46(4). DOI: 10.11665/j.issn.1000-5048.20150408
[6]	Formula optimization and transfection efficiency of polyethyleneimine/DNA complexes[J]. Journal of China Pharmaceutical University, 2010, 41(1): 40-44.
[7]	Study on the Flavonoids from Lonicera confusa DC.[J]. Journal of China Pharmaceutical University, 2004, (4): 9-12.
[8]	Applications of Au Nanoparticles Labeling Method in DNA-detection and the Technology of Genechip[J]. Journal of China Pharmaceutical University, 2003, (2): 88-93.
[9]	The Isoquinolones from Menispermum dauricum DC.[J]. Journal of China Pharmaceutical University, 2001, (2): 16-17.
[10]	Ptotoplast Transformation of Staphylococcal DNA[J]. Journal of China Pharmaceutical University, 1992, (4): 239-242.

Cited By

Cited by

Periodical cited type(3)

1.	石敏，雍琴，何颖娜，黄仕琴，赵轩，余娴. 载铜绿假单胞菌DNA疫苗温敏水凝胶系统的构建及体内评价. 中国药科大学学报. 2021(02): 186-194 . 本站查看
2.	雍琴，岳瀚勋，石敏，黄仕琴，赵轩，余娴. pH响应性PTEN/PLGA-(HE)_(10)-MAP纳米粒的构建及体外评价. 中国药科大学学报. 2021(03): 301-310 . 本站查看
3.	冯旸，徐霄，莫然. 淋巴靶向药物递送系统在抗肿瘤转移治疗中的研究进展. 中国药科大学学报. 2020(04): 425-432 . 本站查看

Other cited types(2)

Get Citation

PDF

XML

Article views (118) PDF downloads (270) Cited by(5)

Turn off MathJax

Article Contents

Abstract

References

Discovery of a new nosiheptide-producing strain and its fermentation optimization for nosiheptide production

Abstract

References

Related Articles

Cited by

Periodical cited type(3)

Other cited types(2)

Catalog

Discovery of a new nosiheptide-producing strain and its fermentation optimization for nosiheptide production

Abstract

References

Related Articles

Cited by

Periodical cited type(3)

Other cited types(2)

Catalog

Export File

Citation

Format

Content